Seoul — September 02, 2026. Published after the market close; equity prices are official closing values. USD/KRW is a continuously traded quote shown as of the close, and a few intraday moves are cited explicitly.
The 30-second version
- The KOSPI dropped 273.08 points, or 3.99%, to close at 6,562.72. It opened 3.08% lower and never meaningfully recovered, at one point trading down about 3.7% and threatening the 6,550 line.
- The KOSDAQ fell 2.10% to 803.98 — a bad day, but notably milder than the main board.
- Three shocks hit at once: renewed US-Iran military clashes near the Strait of Hormuz sent Brent crude above $90, US 10-year Treasury yields climbed to their highest level since January 2025, and Wall Street logged another broad decline.
- Index heavyweights did the damage: Samsung Electronics fell 4.02% and SK hynix 4.73%.
- Biotech was the lone shelter. Several small-cap names surged to Korea’s 30% daily price limit, and medical/precision instruments was the only sector to close higher, up 0.66%.
- The won barely moved: USD/KRW was around 1,368 as of the close, up just 0.08%.
Three shocks landed on the same day
Today’s slide was not about anything Korea-specific — it was Korea absorbing a global risk-off wave with unusual force. The trigger was a re-escalation of military confrontation between the US and Iran near the Strait of Hormuz, the chokepoint through which a large share of the world’s seaborne oil passes. Brent crude broke above $90 a barrel, reviving inflation worries just as US 10-year Treasury yields rose to their highest since January 2025. Wall Street had already fallen for a third straight session — on September 1 the Dow lost 0.79%, the Nasdaq 1.03% and the S&P 500 0.71%, and all four major US indices fell again on September 2 (Blockmedia’s New York close report).
Korea tends to feel this combination acutely. Higher oil is a direct cost shock for an energy importer, higher long-term yields punish growth stocks, and the KOSPI’s heavy weighting in semiconductors means that when global tech sells off, the index has little cushion. Sure enough, the two chip giants — Samsung Electronics (-4.02%) and SK hynix (-4.73%) — were the core reason the benchmark’s loss deepened to nearly 4% (Asiae’s closing report). Rate-sensitive sectors were hit hard too: construction fell 2.77%, transport equipment and parts 3.39%, electrical and electronics 2.67%, manufacturing 2.57%, and machinery 2.45%. Even large-cap defensives were not spared — LG Energy Solution traded down 2.78% and Samsung Biologics 1.41% during the session.
Who was selling — and a caveat on the flow numbers
An important disclosure first: the investor-flow figures available today are a 9:50 a.m. snapshot, taken when the KOSPI was down roughly 2.3-2.6%. Since the index went on to close down 3.99%, the true full-day buying and selling may have been larger than these numbers show. Treat them as a picture of the morning, not the final tally.
As of that snapshot, foreign investors had net sold about 445 billion won (roughly $325 million at today’s rate) and domestic institutions about 612 billion won (roughly $450 million). Retail investors leaned the other way, net buying about 537 billion won (roughly $390 million), with other corporate accounts adding around 520 billion won of net buying. Two things stand out. First, this is the classic crash-day pattern in Korea: foreigners and institutions sell together while retail buys the dip. Second, institutions — not foreigners — were the larger sellers this morning, which suggests the selling pressure was as much domestic de-risking as offshore flight.
Biotech hit the 30% limit while everything else sank
The strangest feature of the day was a full-blown biotech rally inside a 4% market decline. Psomagen (+29.98%), NeoImmuneTech (+29.88%), Nibec (+29.86%) and Genexine (+29.84%) all closed at or near limit-up — Korean stocks cannot move more than 30% in either direction in a single session, a per-stock speed bump similar in spirit to a circuit breaker. N2Tech gained 26.67%, and large-cap Alteogen rose 9.39% to 332,000 won. The pattern on the KOSDAQ looked like rotation: money coming out of the crowded semiconductor trade and into pharma/biotech and secondary batteries, where EcoPro BM added 4.74% to 115,000 won and EcoPro 3.83% to 89,500 won.
A few other pockets held up. Meritz Financial Group, a top-cap financial, gained 4.27%. Refiner S-Oil rose 1.25% — one of the few direct beneficiaries of Brent above $90. But the breadth statistic tells the real story: medical/precision instruments (+0.66%) was the only sector on the KOSPI to finish in the green.
Where things closed
| Item | Close | Change |
|---|---|---|
| KOSPI | 6,562.72 | -273.08 pts (-3.99%) |
| KOSDAQ | 803.98 | -17.27 pts (-2.10%) |
| USD/KRW (as of close) | 1,367.78 | +1.10 won (+0.08%) |
| Samsung Electronics | — | -4.02% |
| SK hynix | — | -4.73% |
| Alteogen | 332,000 won | +9.39% |
| EcoPro BM | 115,000 won | +4.74% |
What to watch next
- Hormuz headlines. Any further US-Iran engagement near the strait is the single biggest driver for oil, the won and Asian equities tomorrow.
- Fed rhetoric. Fed Governor Michael Barr made hawkish comments after the close. If other Fed officials echo that tone, long-term yields — and Korean growth stocks — face more pressure.
- Whether the double-barreled selling continues. Retail buying alone struggled to defend the index today; if foreigners and institutions keep selling together, volatility can extend.
- Defense stocks. These typically gain momentum when geopolitical tension escalates — worth watching their reaction tomorrow.
FAQ
Why did the KOSPI fall almost 4% on September 2, 2026?
Three overlapping shocks: renewed US-Iran military clashes near the Strait of Hormuz pushed Brent oil above $90 and stoked inflation fears, US 10-year yields hit their highest since January 2025, and Wall Street fell for a third straight session. Heavy losses in Samsung Electronics (-4.02%) and SK hynix (-4.73%) then amplified the index decline.
Did foreign investors sell Korean stocks today?
Yes — as of a 9:50 a.m. snapshot, foreigners had net sold about 445 billion won (~$325 million). But domestic institutions were the bigger sellers at about 612 billion won (~$450 million), while retail investors net bought. Because the market fell further after that snapshot, final full-day figures were likely larger.
Why were Korean biotech stocks surging while the market crashed?
Sector rotation. Money moved out of the crowded semiconductor trade into pharma/biotech and battery names, sending Psomagen, NeoImmuneTech, Nibec and Genexine to gains of nearly 30% each. Medical/precision instruments was the only sector to close higher.
What does \”limit-up\” mean in the Korean market?
Korean exchange rules cap any single stock’s daily move at plus or minus 30% from the prior close. A stock that rises the full 30% is \”limit-up\” and effectively cannot trade higher that day — a per-stock brake designed to slow extreme moves.
Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.
Also on Seoul Closing Bell
A companion piece on the same session, written from a different angle: Institutions Led KOSPI's 3.99% Selloff, Not Foreigners.